LOS ANGELES, CA - March 10, 2026 (NEWMEDIAWIRE) - Soligenix (NASDAQ: SNGX) announced that SGX945 (dusquetide) has received Promising Innovative Medicine ("PIM") designation from the U.K. Medicines and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results